Intracranial Support Catheter Global Market Report 2025

The intracranial support catheter market size has grown strongly in recent years. It will grow from $1.09 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth observed in the historic period can be attributed to the increasing prevalence of neurological disorders, a rise in surgical procedures, the expanding aging population, a higher incidence of cerebrovascular disease, and a growing demand for medical devices.

The intracranial support catheter market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth anticipated in the forecast period is driven by higher government investments in healthcare, an increased demand for medical devices, rising healthcare expenditures, greater awareness of neurological disorders, and a growing elderly population. Key trends for the forecast period include progress in AI-driven surgical planning, the integration of real-time monitoring systems, innovations in catheter materials, advancements in biocompatible coatings, and developments in minimally invasive techniques.

The growing prevalence of neurological disorders is expected to drive the expansion of the intracranial support catheter market in the future. Neurological disorders refer to diseases affecting the brain, spinal cord, and nerves, leading to impairments in movement, sensation, cognition, or other bodily functions. This increase in neurological disorders is largely attributed to the aging population, as older adults are more vulnerable to conditions such as dementia and Parkinson's disease. Intracranial support catheters are particularly beneficial for managing neurological disorders as they offer a direct pathway for delivering medications or draining cerebrospinal fluid (CSF), which is crucial for managing conditions such as hydrocephalus, brain injuries, or intracranial pressure imbalances. For example, in May 2024, the Alzheimer's Society, a UK-based care and research charity, reported that 55 million people globally are living with dementia, a neurological disorder, and this number is expected to reach 139 million by 2050. Thus, the increasing prevalence of neurological disorders is a key factor driving market growth.

Companies in the intracranial support catheter market are focusing on obtaining regulatory approvals to broaden their product offerings and increase market access. Regulatory approvals are official authorizations granted by regulatory bodies such as the FDA, confirming that a medical device or product meets the necessary safety, efficacy, and quality standards for legal use in the market. For instance, in September 2023, MicroVention Inc., a US-based medical device company, announced that its SOFIA EX 5F 115 cm intracranial support catheter received FDA 510(k) clearance. The SOFIA EX catheter, which stands for Soft TOrqueable catheter For Intracranial Access, is designed to offer better support during neurovascular procedures, especially for accessing the intracranial vasculature. This clearance allows MicroVention to market the catheter for clinical use in various neurovascular interventions, improving clinical outcomes and enhancing the safety and efficiency of treatments for patients with neurovascular conditions.

In March 2025, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering company, acquired SoniVie Ltd. for an undisclosed amount. This acquisition aims to enhance Boston Scientific’s interventional cardiology therapies portfolio by adding an ultrasound-based renal denervation therapy for treating hypertension. The therapy offers a minimally invasive alternative or adjunctive treatment to medications for blood pressure regulation. SoniVie Ltd., based in Israel, specializes in innovative intravascular ultrasound (IVUS) technology for therapeutic applications.

Major players in the intracranial support catheter market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Wallaby Medical Holding Inc., Terumo Corporation, Cook Medical Incorporated, Integer Holdings Corporation, Penumbra Inc., MicroPort Scientific Corporation, Imperative Care Inc., Phenox GmbH, Rapid Medical, Balt USA LLC, Prytime Medical Devices Inc., Acandis GmbH, Shanghai HeartCare Medical Technology Corporation, Zylox-TonBridge Medical Technology Co. Ltd., Mivi Neuroscience Inc., and BioCardia Inc.

North America was the largest region in the intracranial support catheter market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intracranial support catheter report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intracranial support catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An intracranial support catheter is a specialized medical device designed for use in neurovascular procedures, providing stability to help navigate microcatheters and deliver treatment tools within the blood vessels of the brain. It aids in procedures such as thrombectomy and aneurysm repair by helping to navigate the brain’s intricate blood vessel anatomy, thereby improving the success and safety of these interventions.

The primary types of intracranial support catheters are ventricular catheters, subarachnoid catheters, intracerebral catheters, and drainage catheters. Ventricular catheters are flexible tubes that are inserted into the brain's ventricles to drain excess cerebrospinal fluid (CSF), commonly used in the treatment of hydrocephalus and in reducing intracranial pressure. These catheters are distributed through direct sales, distributors, wholesalers, online platforms, and retail pharmacies, serving a range of applications including neurovascular disorders, hydrocephalus treatment, and traumatic brain injury. They are used by various end users such as hospitals, specialty clinics, research institutions, and home care environments.

The intracranial support catheter market research report is one of a series of new reports that provides intracranial support catheter market statistics, including intracranial support catheter industry global market size, regional shares, competitors with an intracranial support catheter market share, detailed intracranial support catheter market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial support catheter industry. This intracranial support catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intracranial support catheter market consists of sales of distal access catheters, intermediate catheters, aspiration catheters, and steerable support catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.